Skip to main content
. 2005 Sep;91(9):1167–1172. doi: 10.1136/hrt.2004.038620

Figure 3.

Figure 3

 Kaplan-Meier survival analysis (cumulative proportion surviving) of 57 patients with ARVD/C (time from correct diagnosis to cardiac death or heart transplantation) comparing the group of patients with left ventricular abnormalities (LVA) (n  =  23) with the group without LVA (n  =  34) (p  =  0.0003). The numbers of patients remaining at risk for death or heart transplantation during follow up (FU) are listed beneath the plot.